Yunnan Baiyao Group Co.,Ltd (SHE:000538)

Market Cap	99.04B -4.4%
Revenue (ttm)	40.77B +3.6%
Net Income	5.20B +21.0%
EPS	2.92 +21.6%
Shares Out	1.78B
PE Ratio	19.02
Forward PE	16.17
Dividend	2.20 (3.96%)
Ex-Dividend Date	Sep 24, 2025

Volume	6,909,038
Average Volume	10,226,110
Open	55.90
Previous Close	55.51
Day's Range	55.39 - 56.00
52-Week Range	53.56 - 60.69
Beta	0.38
RSI	40.22
Earnings Date	Apr 1, 2026

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China. The company offers health products; drugs; chemical raw materials, chemical preparations, sales of chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines, biological products, medical devices, health food, food, beverages, special labor protection products, production and sales of daily chemical products, cosmetics and outdoor products; production and sales of rubber plasters, plasters, disinfection products, electronic and di...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 9,277
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2024, SHE:000538's revenue was 40.03 billion, an increase of 2.36% compared to the previous year's 39.11 billion. Earnings were 4.75 billion, an increase of 16.02%.